J7352 Afamelanotide implant, 1 milligrams
Also known as: Scenesse, afamelanotide implant, alpha-MSH analog
Subdermal implant of afamelanotide (melanotan II analog), 1 milligram, for treatment of erythropoietic protoporphyria.
In Plain Language
sun sensitivity treatment; skin protection implant
Clinical Context
Indicated for treatment of erythropoietic protoporphyria to reduce phototoxic reactions to sunlight exposure.
RVU Information
CPT J7352 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J7352?
CPT J7352 (Afamelanotide implant, 1 milligrams) is a J Codes (Drugs) code. Subdermal implant of afamelanotide (melanotan II analog), 1 milligram, for treatment of erythropoietic protoporphyria.
How is J7352 administered?
CPT J7352 is administered by a healthcare provider, typically via injection or infusion. Indicated for treatment of erythropoietic protoporphyria to reduce phototoxic reactions to sunlight exposure. It is used by Dermatology, Genetics, Internal Medicine.
When is CPT J7352 used?
Indicated for treatment of erythropoietic protoporphyria to reduce phototoxic reactions to sunlight exposure.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.